Biotechnology News

July 25, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that recognized food industry experts Dave Pfanzelter and David Theno, Jr., Ph.D. have joined...

July 25, 2012

PERKASIE, Pa.--(BUSINESS WIRE)--Secant Medical® announced today that it has received industry analyst Frost & Sullivan’s 2012 North American Enabling Technology Award for its medical implantable textile structures design approach.

July 25, 2012

SAN DIEGO--(BUSINESS WIRE)--bioTheranostics, Inc., today announced that Mary Jo Mullen, chief commercial officer, and Isaac J. Bright, MD, vice president, corporate development, have joined the company’s senior management team.

July 25, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics (NYSE MKT: IMUC) today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase...

July 25, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS) today announced its financial results for the quarter ended June 30, 2012.

July 25, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb’s Second Quarter Highlighted by the Planned Strategic Acquisition of Amylin Pharmaceuticals and Important Clinical Data in Immuno-Oncology

July 25, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its partner GlaxoSmithKline (NYSE: GSK) has been granted priority review from the US Food and Drug Administration for the supplemental new drug...

July 25, 2012

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) (Alexion or the Company) today announced financial results for the three and six months ended June 30, 2012. Alexion reported net product sales of Soliris® (eculizumab...

July 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, today announced the successful completion of a $60 million Series D financing. In this round, new investors...

July 25, 2012

LIVINGSTON, N.J.--(BUSINESS WIRE)--Columbia Laboratories Inc. (Nasdaq: CBRX) will hold a conference call on August 8, 2012, to discuss financial results of the three- and six-month periods ended June 30, 2012. Frank Condella, president and chief...

July 25, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 30, 2012. Second Quarter Highlights Adjusted earnings per...

July 25, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Extends Joint Venture Negotiations with Amarantus

July 25, 2012

SAFFRON WALDEN, England--(BUSINESS WIRE)--BioFocus announced a strategic alliance which will allow it to offer Activiomics’ proteomics services to its customers, to improve identification of novel targets for drug discovery and biomarkers.

July 25, 2012

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-U.S. and Non-UK Media Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) received Marketing Authorisation from the European Commission for Jentadueto® which combines the DPP-4 inhibitor,...

July 25, 2012

LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma AG, a leading producer of human proteins for life saving therapies, presents symposium on inhibitor prevention in haemophilia A treatment with Factor VIII concentrate at WFH World Congress

July 25, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc today reported its second quarter and first half 2012 financial results. “Progress continued during the course of the second quarter,” said Mr. Kelly Martin, chief executive officer. “Underlying...

July 25, 2012

GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, successfully closed the first six months of 2012, with substantial gains in order intake, sales revenue and...

July 24, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics cut spending by 20%, raised capital, focused its business plan, and continued to build the foundation needed to move clinical programs forward.

July 24, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--Durata Therapeutics (NASDAQ: DRTX) today announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price of $9.00 per share, before underwriting discounts,...

July 24, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the second quarter of 2012. Second quarter 2012 results: Revenue of $281 million, a 2% decrease compared to $287 million in the second quarter of...

July 24, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma announced that it has appointed Andrew Robbins to the position of Senior Vice President of Commercial Operations.

July 24, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--At their meeting today, the Board of Directors of Merck & Co., Inc. declared a quarterly dividend of $0.42 per share on the company’s common stock for the fourth quarter of 2012. Payment will be made...

July 24, 2012

OKLAHOMA CITY--(BUSINESS WIRE)--SensiQ Technologies, Inc. has been acquired by private equity firm TechVen Partners, and will seek to aggressively expand the market reach of its Label-Free SPR.

July 24, 2012

WASHINGTON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced two-year Phase 3 clinical trial results showing that the integrase inhibitor elvitegravir dosed once daily is non-inferior to raltegravir dosed twice daily among...

July 24, 2012

WASHINGTON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced 24-week data from a Phase 3 clinical trial, SPIRIT (Switching boosted PI to Rilpivirine In Combination with Truvada as a Single Tablet Regimen), which evaluated...

July 24, 2012

WASHINGTON--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced full clinical trial results from a pivotal Phase 3 study evaluating cobicistat, a pharmacoenhancing or “boosting” agent for HIV therapy, compared to ritonavir, which...

July 24, 2012

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--The 2012 Transplant Games of America are quickly approaching and Spectrum Health employees are working in force to assist the West Michigan Sports Commission (WMSC) in hosting a successful event. Events take...

July 24, 2012

BERWYN, Pa.--(BUSINESS WIRE)--QR Pharma, Inc. is initiating the first human clinical trial of bisnorcymserine, its compound to treat advanced Alzheimer's disease, to evaluate safety and tolerability in elderly healthy volunteers

July 24, 2012

PARSIPPANY, N.J.--(BUSINESS WIRE)--IMS Health plans to post for note holders its second-quarter 2012 financial results on Monday, July 30, 2012. The company will conduct a conference call for IMS’s note holders to review these results at 1:00 p.m...

July 24, 2012

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced today the availability of...

July 24, 2012

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTC:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that its senior management will hold a conference call on...

July 24, 2012

MAYNARD, Mass.--(BUSINESS WIRE)--Allegro Diagnostics announced the completion of enrollment into the 1320-patient AEGIS II clinical trial, evaluating the diagnostic ability of BronchoGen to detect early signs of lung cancer.

July 24, 2012

DENVER--(BUSINESS WIRE)--The TriZetto Group, Inc., announced today it has engaged with BlueCross BlueShield of Tennessee as a strategic advisor and technology partner to collaborate...

July 24, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--New SEEDS supplier added to Premier’s equipment planning, procurement, installation and transition planning services portfolio

July 24, 2012

SOMERSET, N.J.--(BUSINESS WIRE)--Catalent announced it has commenced supply to Otsuka Pharmaceutical Co., Ltd. of Abilify® OD Tablets (orally disintegrating tablets (ODT)), which utilize Catalent’s Zydis® fast dissolve drug delivery technology....

July 24, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced it has appointed Lawrence Guiheen...

July 24, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--Right Brain Networks, a cloud-based application development and hosting company, offers clients faster performance and more control over their hosting investment with Online Tech’s HIPAA and SSAE 16 compliant...

July 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Receives State of Connecticut Clinical Laboratory Licensure and CLIA Certificate of Registration for Global DNA Sequencing Services

July 24, 2012

NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) (“Forest”) today announced that the Company has filed a presentation with the Securities and Exchange Commission (“SEC”) in connection with its Annual Meeting of Shareholders to be...

July 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Regenerative medicine company Histogenics Corporation, announced today the completion of a $49 million round of financing. Funds will be used to advance NeoCart for treatment of knee cartilage injury.

July 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that Lawrence Bloch, M.D., J.D., has joined Infinity as executive vice president, chief financial officer and chief business officer. In this role,...

July 24, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced that National Government Services, the designated Medicare fiscal intermediary in Connecticut, has confirmed coverage for its proprietary Clopidogrel Genetic...

July 24, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research has named Shannon Gordon as vice president of global project management.

July 24, 2012

CINCINNATI--(BUSINESS WIRE)--Camargo Pharmaceutical Services successfully completed five Food and Drug Administration (FDA) pre-IND meetings for 505(b)(2) products in the month of June.

July 24, 2012

WESTON, Mass.--(BUSINESS WIRE)--Second graph after the first series of bullets should read: The company also completed its previously ... (sted During the second quarter, the company also completed its previously ...). The corrected release reads...

July 24, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) today announced it will report financial results for the second quarter of 2012 before the NASDAQ Global Market opens on Thursday, August 2. The earnings press release will be...